Joseph Hoang

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B

Yao‐Chun Hsu, Grace Lai‐Hung Wong, Chien‐Hung Chen et al. · The American Journal of Gastroenterology · 2019 · 101 citations

Pharmacy, Oncology, Pharmacotherapy +16

Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy

Hwai‐I Yang, Ming‐Lun Yeh, Grace Lai‐Hung Wong et al. · The Journal of Infectious Diseases · 2019 · 98 citations

Medicine, Oncology, Clinical Epidemiology +16

Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B

Jie Li, Hwai‐I Yang, Ming‐Lun Yeh et al. · The Journal of Infectious Diseases · 2020 · 97 citations

Medicine, Biostatistics, Oncology +17

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

Daniel Q. Huang, Andrew Tran, Ming‐Lun Yeh et al. · Hepatology · 2023 · 89 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B

Yao‐Chun Hsu, Ming‐Lun Yeh, Grace Lai‐Hung Wong et al. · The Journal of Infectious Diseases · 2021 · 83 citations

Pharmacy, Pharmacotherapy, Clinical Epidemiology +16